Efficacy News and Research

RSS

New approach identifies epigenetic changes in leukemia cells for patients undergoing ibrutinib treatment

Many new anti-cancer drugs inhibit proteins that are essential for the proliferation of cancer cells. One example is ibrutinib, an innovative therapy for chronic lymphocytic leukemia first approved in 2014.

29 Jan 2019

NIH grants awarded to Nanoscope to recruit talent and develop optogenetic delivery platforms

Retinal dystrophies such as Age-related macular degeneration (AMD) are a major cause of vision loss in aging populations. National Eye Institute (NEI) estimates that the prevalence of advanced AMD will grow to nearly 3 million by 2020.

29 Jan 2019

GW researchers engineer nanoimmunotherapy to treat cancer

A team from the George Washington University Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer.

28 Jan 2019

'Bug bombs' are ineffective at removing cockroaches from indoor environments

Total release foggers, commonly known as "bug bombs," are ineffective at removing cockroaches from indoor environments, according to a new study from North Carolina State University.

28 Jan 2019

Newly designed drugs could help combat any potential flu pandemic

Researchers at LSTM and Imperial College London have designed drugs which could help combat any potential new flu pandemic, by targeting the receptors of the cells by which the virus gains entry to the human body.

28 Jan 2019

UK launches plans to help combat antimicrobial resistance by 2040

The UK government has launched a 5-year action plan outlining how the nation intends to contribute to the containment and control of antimicrobial resistance by the year 2040.

25 Jan 2019

Combination of cystic fibrosis drugs found to be safe and effective in children aged 2-5 years

An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children aged 2-5 years, whose disease is caused by two copies of F508del-CFTR gene mutation - the most common and severe form of cystic fibrosis.

25 Jan 2019

Clinical Design launches world’s only hygienic digital urine test at Arab Health 2019

The world’s only hygienic, easy-to-use and accurate digital point-of-care urine test is being launched at Arab Health 2019 by UK company, Clinical Design.

24 Jan 2019

Confident people more likely to recover from shoulder pain

People are more likely to recover from shoulder pain if they have the confidence to carry on doing most things, despite their pain - according to new research from the University of East Anglia and University of Hertfordshire.

24 Jan 2019

Global task force of bone health experts question effectiveness of spinal fusion procedures

There is little to no evidence that two surgical procedures used to fuse crumbled vertebrae following a spinal fracture caused by osteoporosis reduce pain for patients any better than non-surgical or placebo procedures, according to a new report from a global task force of bone health experts published today in the Journal of Bone and Mineral Research.

24 Jan 2019

CMV vaccine provides a new way to fight malaria

Early research on a new approach to protecting against malaria is offering promising, potentially long-lasting results against the persistent parasite that sickens hundreds of millions people each year.

24 Jan 2019

Benzodiazepines may improve survival in congestive heart failure

A study published in the current issue of Psychotherapy and Psychosomatics indicates that treatment of anxiety with benzodiazepines may improve survival in congestive heart failure.

23 Jan 2019

Lab-Scale Clarification of Mammalian Cell Cultures Expressing Recombinant Antibodies

Tina Stoschek and Marcus Gerlach discuss maximizing mAb generation using lab-scale clarification of cell cultures expressing recombinant antibodies.

From Sartorius 23 Jan 2019

UC team designs new naloxone-dispensing smart device

Like many cities across the country, Cincinnati has been rocked by the opioid epidemic, with an ever-fluctuating range of 50 to 80 overdoses per week across the Tristate. Many of those victims are revived by the overdose reversal medication, naloxone, which has proven to be a crucial lifesaving tool during this crisis.

23 Jan 2019

Aspirin may reduce stroke risk in preeclamptic women

Middle-aged women with a history of preeclampsia have a greater risk of stroke, and aspirin may be able to reduce the risk, according to a new study led by researchers at Columbia University Vagelos College of Physicians & Surgeons.

23 Jan 2019

Skin samples hold early signs of prion disease, research suggests

Prions can infect both humans and animals, causing Creutzfeldt-Jakob disease in humans, mad cow disease in cattle, and chronic wasting disease in elk and deer. The infectious, misfolded protein particles often go undetected as they destroy brain tissue, causing memory loss, mobility issues, and ultimately death.

23 Jan 2019

Groundbreaking tool helps visualize neuronal activity with near-infrared light

A new, groundbreaking tool for visualizing neural activity has implications for understanding brain functions and disorders, according to new research by University of Alberta scientists and a team of international collaborators.

22 Jan 2019

Examing the effects of menopause in workplace

As The Open University celebrates its 50th anniversary and its track record for research which turns ideas into solutions that benefit people, business and society, Jo Brewis, Professor of People and Organizations in The Faculty of Business and Law will examine the effects of menopause and call for employers to pay careful attention to it.

22 Jan 2019

The Psychology Behind Sticking to Your New Year’s Resolutions

Despite good intentions, most people will not achieve their goal. Could psychology provide the answer to creating and sticking to your new year resolutions?

22 Jan 2019

Study to investigate new targeted oral treatments for severe asthma

A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.

21 Jan 2019